この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2003/5/281 分で読めます
Determination That Periactin Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) has determined that Periactin (cyproheptadine hydrochloride (HCl)) 4-milligram (mg) tablets were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for cyproheptadine HCl 4-mg tablets.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →